Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer

Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer

BackgroundThis study aimed to evaluate the efficacy and safety of pyrotinib in the treatment of HER2-positive breast cancer patients with and without liver metastasis.MethodsA retrospective analysis was conducted on 91 patients with HER2-positive advanced breast cancer, who were treated with pyrotin...

Full description

Saved in:
Bibliographic Details
Main Authors: Yongxia Li, Yong Li, Taolang Li, Mingyuan He, Jianying Chang, Hui Cao, Daiqin Luo, Junyuan Lv, Yunbi Zou, Yuyan Zheng, Li Ran, Feiyue Yang, Li Huang, Xiaoming Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Oncology
Subjects:
breast cancer
pyrotinib
HER2-positive
liver metastasis
efficacy and safety
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1527277/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items